KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Amortizatization of Intangibles (2018 - 2025)

Castle Biosciences' Amortizatization of Intangibles history spans 5 years, with the latest figure at $708000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 56.11% year-over-year to $708000.0; the TTM value through Dec 2025 reached $4.2 million, down 36.89%, while the annual FY2025 figure was $4.2 million, 36.89% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $708000.0 at Castle Biosciences, down from $905000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.7 million in Q2 2024 and bottomed at $184000.0 in Q3 2022.
  • The 4-year median for Amortizatization of Intangibles is $1.3 million (2023), against an average of $1.3 million.
  • The largest annual shift saw Amortizatization of Intangibles surged 752.72% in 2023 before it tumbled 56.11% in 2025.
  • A 4-year view of Amortizatization of Intangibles shows it stood at $1.2 million in 2022, then surged by 38.51% to $1.6 million in 2023, then decreased by 1.65% to $1.6 million in 2024, then crashed by 56.11% to $708000.0 in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Amortizatization of Intangibles are $708000.0 (Q4 2025), $905000.0 (Q3 2025), and $1.2 million (Q2 2025).